Protein kinases are relevant pharmaceuticaltargets because of their important role in cell signaling and cancer.They activate and inactivate other proteins via phosphorylation ofthe hydroxyl group of a serine, threonine, or tyrosine residue. The gene discussed is WEE1; the disease is cancer.